2009
DOI: 10.1176/appi.ps.60.2.258
|View full text |Cite
|
Sign up to set email alerts
|

How Quality Improvement Interventions for Depression Affect Stigma Concerns Over Time: A Nine-Year Follow-Up Study

Abstract: Objective To examine the long-term impact of two quality improvement interventions for depression on stigma concerns in primary care compared to usual care. Method Data are from nine-year follow-up of participants in Partners in Care, a group level randomized trial comparing those enrolled in the interventions with enhanced resources for therapy (QI-therapy) or medication management (QI-meds) on stigma concerns about friends, health insurance companies, and employers learning about histories of depression or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
(1 reference statement)
1
1
0
Order By: Relevance
“…Such an explanation is broadly consistent with research on social distance, wherein exposure to the stigmatized context (that is, treatment) can lead to decreases in desired social distance (19). Second, the results are also consistent with research showing that levels of stigma change in association with treatment (31). Finally, the relationship between PDD and depression had already been established (7), and the current measures’ correlations with depression were comparable with those of the PDD.…”
Section: Discussionsupporting
confidence: 87%
“…Such an explanation is broadly consistent with research on social distance, wherein exposure to the stigmatized context (that is, treatment) can lead to decreases in desired social distance (19). Second, the results are also consistent with research showing that levels of stigma change in association with treatment (31). Finally, the relationship between PDD and depression had already been established (7), and the current measures’ correlations with depression were comparable with those of the PDD.…”
Section: Discussionsupporting
confidence: 87%
“…Our informants received a range of treatments, and some received no treatment despite a positive screen. However, in a separate analysis, participants from the PIC study treated by primary care clinicians receiving enhanced resources for the delivery of therapy showed reduced stigma concerns compared to other participants; while those participants treated by clinicians receiving enhanced resources to support medication management showed increased stigma concerns compared to others (Klap, et al 2009). As do informants' narratives, these analyses suggest that primary care pharmaceutical treatment of depression may increase stigma.…”
Section: Resultsmentioning
confidence: 97%